Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 45.0
(0.0%)
JPY 45.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -59.04 Million JPY | -2526.88% |
| 2022 | 2.43 Million JPY | 104.11% |
| 2021 | -59.23 Million JPY | -256.77% |
| 2020 | 37.78 Million JPY | 182.23% |
| 2019 | -45.94 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.99 Million JPY | 124.39% |
| 2024 Q2 | -13.41 Million JPY | -7.56% |
| 2023 Q3 | 9.9 Million JPY | 24.59% |
| 2023 FY | -59.04 Million JPY | -2526.88% |
| 2023 Q2 | 7.94 Million JPY | 152.99% |
| 2023 Q1 | 3.14 Million JPY | 43.08% |
| 2023 Q4 | -16.37 Million JPY | -265.32% |
| 2022 Q3 | -14.5 Million JPY | 0.0% |
| 2022 FY | 2.43 Million JPY | 104.11% |
| 2022 Q4 | 2.19 Million JPY | 115.14% |
| 2021 FY | -59.23 Million JPY | -256.77% |
| 2020 FY | 37.78 Million JPY | 182.23% |
| 2019 FY | -45.94 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 103.139% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | 173.526% |
| GNI Group Ltd. | 22.43 Billion JPY | 100.263% |
| Linical Co., Ltd. | 3.77 Billion JPY | 101.563% |
| Trans Genic Inc. | 2.24 Billion JPY | 102.625% |
| MEDINET Co., Ltd. | 98.25 Million JPY | 160.096% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 102.379% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 104.568% |
| AnGes, Inc. | -3.06 Billion JPY | 98.074% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 66.775% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 100.611% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 111.414% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 153.216% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 104.07% |
| CanBas Co., Ltd. | -984 Million JPY | 93.999% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 115.074% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 103.565% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 114.814% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 105.681% |
| PeptiDream Inc. | 17.21 Billion JPY | 100.343% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | 292.929% |
| Ribomic Inc. | -10.5 Million JPY | -462.236% |
| SanBio Company Limited | -14.5 Million JPY | -307.101% |
| Healios K.K. | 108 Million JPY | 154.672% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | -17215.543% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | -3805.159% |
| StemRIM | -44.34 Million JPY | -33.139% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 101.854% |
| FunPep Company Limited | -680.28 Million JPY | 91.32% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 185.265% |
| Stella Pharma Corporation | 217.29 Million JPY | 127.173% |
| TMS Co., Ltd. | -6.95 Million JPY | -749.583% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 118.771% |
| Cuorips Inc. | 9.63 Million JPY | 713.083% |
| K Pharma,Inc. | 910 Million JPY | 106.489% |
| Takara Bio Inc. | 25.45 Billion JPY | 100.232% |
| ReproCELL Incorporated | 1.1 Billion JPY | 105.345% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 104.941% |
| StemCell Institute Inc. | 1.57 Billion JPY | 103.747% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 103.543% |
| CellSeed Inc. | 107.15 Million JPY | 155.103% |